/ /

  • linkedin
  • Increase Font
  • Sharebar

    Biologic products increase dry eye options

    Autologous serum, most commonly used, has benefits and drawbacks



    Other approaches

    Other biologic products, including amniotic membrane, are available to treat dry eye. Use of mesenchymal stem cells is another potential therapy under investigation.

    Infliximab (Remicade, Janssen), an anti-tumor necrosis factor therapy, is another biologic product, as is etanercept (Enbrel, Amgen), used to treat rheumatoid arthritis.

    “Sometimes the underlying cause of dry eye is rheumatoid arthritis,” Dr. Jeng said. “Technically, a lot of dry eye patients are on biologics, just not the topical forms that you might think about.”

    Despite the current focus on biologics, Dr. Jeng believes, it is important to determine first whether the patient’s problem actually is dry eye, rather than something else.

    “If you don’t make the right diagnosis, you’re barking up the wrong tree and you’ll never make them better,” Dr. Jeng said.


    Bennie H. Jeng, MD

    e: [email protected]

    This article was adapted from Dr. Jeng’s presentation during Cornea Day at the 2017 meeting of the American Society of Cataract and Refractive Surgery. Dr. Jeng has no financial interest in the subject matter.


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results